Literature DB >> 29759563

Targeting the tumor promoting effects of adenosine in chronic lymphocytic leukemia.

Yiqing Cai1, Lili Feng2, Xin Wang3.   

Abstract

Chronic lymphocytic leukemia (CLL) is a hematological malignancy which is characterized by progressive accumulation of functionally deficient B cells in blood, bone marrow, and lymphatic tissue. The tumor microenvironment (TME) appears to play a critical role in genesis and progression of CLL. High levels of extracellular adenosine (ADO) are detected in CLL as a consequence of expression of ecto-enzymes, such as CD39 and CD73. Extracellular ADO exhibits a broad range of effects on cell cycle control, immunoregulation, angiogenesis and cytokine regulation through both direct and indirect mechanisms. In this review, we focused on the multiple functions and related mechanisms of ADO signaling in CLL generation and progression.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenosine; Chronic lymphocytic leukemia; Tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 29759563     DOI: 10.1016/j.critrevonc.2018.03.022

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  4 in total

1.  Role of exosome-associated adenosine in promoting angiogenesis.

Authors:  Nils Ludwig; Edwin K Jackson; Theresa L Whiteside
Journal:  Vessel Plus       Date:  2020-04-10

Review 2.  Tick Salivary Compounds for Targeted Immunomodulatory Therapy.

Authors:  Hajer Aounallah; Chaima Bensaoud; Youmna M'ghirbi; Fernanda Faria; Jindr Ich Chmelar; Michail Kotsyfakis
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

Review 3.  Checkpoint Inhibitors and Engineered Cells: New Weapons for Natural Killer Cell Arsenal Against Hematological Malignancies.

Authors:  Massimo Giuliani; Alessandro Poggi
Journal:  Cells       Date:  2020-06-29       Impact factor: 6.600

Review 4.  The role of the metabolite cargo of extracellular vesicles in tumor progression.

Authors:  Mária Harmati; Mátyás Bukva; Tímea Böröczky; Krisztina Buzás; Edina Gyukity-Sebestyén
Journal:  Cancer Metastasis Rev       Date:  2021-12-27       Impact factor: 9.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.